Tech Company Financing Transactions
Coherus BioSciences Funding Round
Coherus BioSciences closed a $28 million venture capital round on 7/25/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
7/25/2013
Transaction Type
Debt
Amount
$28,000,700
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
333 Twin Dolphin Dr. 600
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Website
Email Address
Not Recorded
Overview
Coherus Biosciences is a leading developer of high-quality biosimilar therapeutics with a robust biosimilar pipeline aimed to improve biologic drugs access.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Lanfear
Chief Financial Officer
Jean-Frederic Viret
Chief Medical Officer
Barbara Finck
Chief Technical Officer
Peter Watler
Executive Vice President
Vince Anicetti
Executive Vice President
Vladimir Vexler
VP - Bus. Development
Erik Wiberg
VP - Sales
Michael Fleming
Browse more venture capital transactions:
Prev: 7/25/2013: Brazen venture capital transaction
Next: 7/25/2013: Blue Cod Technologies venture capital transaction
Share this article
News on VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs